C2N DIAGNOSTICS has a total of 20 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets measurement, pharmaceuticals and computer technology are PREVENTAGE HEALTHCARE LLC, AMPRION INC and ONCIMMUNE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Canada | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Australia | 2 | |
#6 | Argentina | 1 | |
#7 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Pharmaceuticals | |
#3 | Computer technology |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Therapeutic chemical compounds | |
#3 | Bioinformatics | |
#4 | Electric digital data processing |
# | Name | Total Patents |
---|---|---|
#1 | West Tim | 18 |
#2 | Paoletti Andrew Corey | 11 |
#3 | Paoletti Andrew C | 7 |
#4 | Tim West | 2 |
#5 | Diljeet S Athwal | 1 |
#6 | Andrew C Paoletti | 1 |
#7 | Timothy D Jones | 1 |
#8 | Robert Holgate | 1 |
#9 | Francis J Carr | 1 |
Publication | Filing date | Title |
---|---|---|
US2014315327A1 | Methods for Measuring Concentrations of Biomolecules | |
CA2848915A1 | Methods for the diagnosis and treatment of neurological and neurodegenerative diseases and disorders using labeled alpha syruclein | |
EP2373988A1 | Methods for measuring concentrations of biomolecules |